146 related articles for article (PubMed ID: 31682773)
1. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.
Zhou T; Bloomquist MS; Ferguson LS; Reuther J; Marcogliese AN; Elghetany MT; Roy A; Rao PH; Lopez-Terrada DH; Redell MS; Punia JN; Curry CV; Fisher KE
Pediatr Hematol Oncol; 2020 Feb; 37(1):76-89. PubMed ID: 31682773
[TBL] [Abstract][Full Text] [Related]
2. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411
[TBL] [Abstract][Full Text] [Related]
3. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
Xu LH; Wang Y; Chen ZY; Fang JP
J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21).
Hu G; Lu A; Wu J; Jia Y; Zuo Y; Ding M; Zhang L
Pediatr Hematol Oncol; 2021 Feb; 38(1):14-24. PubMed ID: 32803999
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
Kaur V; Swami A; Alapat D; Abdallah AO; Motwani P; Hutchins LF; Jethava Y
Hematology; 2018 Jan; 23(1):17-24. PubMed ID: 28574302
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.
Kawamoto K; Miyoshi H; Yoshida N; Takizawa J; Sone H; Ohshima K
Am J Surg Pathol; 2016 Nov; 40(11):1473-1483. PubMed ID: 27631510
[TBL] [Abstract][Full Text] [Related]
7. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.
Creutzig U; Zimmermann M; Reinhardt D; Rasche M; von Neuhoff C; Alpermann T; Dworzak M; Perglerová K; Zemanova Z; Tchinda J; Bradtke J; Thiede C; Haferlach C
Cancer; 2016 Dec; 122(24):3821-3830. PubMed ID: 27529519
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.
Taga T; Imamura T; Nakashima K; Maeda N; Watanabe A; Miyajima Y; Sakaguchi S; Sano H; Hasegawa D; Kawasaki H; Adachi S; Takagi M; Koh K; Manabe A; Taki T; Ishida Y
Int J Hematol; 2018 Oct; 108(4):438-442. PubMed ID: 29971602
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular characterization of myeloid sarcoma without medullary leukemia.
Abbas HA; Reville PK; Geppner A; Rausch CR; Pemmaraju N; Ohanian M; Sasaki K; Borthakur G; Daver N; DiNardo C; Bueso-Ramos C; Pierce S; Jabbour E; Garcia-Manero G; Konopleva M; Ravandi F; Kantarjian H; Kadia TM
Leuk Lymphoma; 2021 Dec; 62(14):3402-3410. PubMed ID: 34380367
[TBL] [Abstract][Full Text] [Related]
10. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Extramedullary Infiltration in Pediatric Low-risk Acute Myeloid Leukemia: A Retrospective Single-center Study Over 10 Years.
Hu GH; Lu AD; Jia YP; Zuo YX; Wu J; Zhang LP
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e813-e820. PubMed ID: 32680776
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
Lazzarotto D; Candoni A; Filì C; Forghieri F; Pagano L; Busca A; Spinosa G; Zannier ME; Simeone E; Isola M; Borlenghi E; Melillo L; Mosna F; Lessi F; Fanin R
Leuk Res; 2017 Feb; 53():74-81. PubMed ID: 28056398
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system involvement by myeloid sarcoma: a report of 12 cases and review of the literature.
Olar A; Lapadat R; Davidson CJ; Stein TD; Dahiya S; Perry A; Gheorghe G
Clin Neuropathol; 2016; 35(5):314-25. PubMed ID: 27125868
[TBL] [Abstract][Full Text] [Related]
15. Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group.
Samborska M; Barańska M; Wachowiak J; Skalska-Sadowska J; Thambyrajah S; Czogała M; Balwierz W; Kołtan S; Peszyńska-Żelazny K; Wysocki M; Ociepa T; Urasiński T; Wróbel G; Węcławek-Tompol J; Ukielska B; Chybicka A; Kitszel A; Krawczuk-Rybak M; Szmydki-Baran A; Malinowska I; Matysiak M; Mizia-Malarz A; Tomaszewska R; Szczepański T; Chodała-Grzywacz A; Karolczyk G; Maciejka-Kembłowska L; Irga-Jaworska N; Badowska W; Dopierała M; Kurzawa P; Derwich K
Front Oncol; 2022; 12():935373. PubMed ID: 35875115
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics, genetics and prognosis of patients with myeloid sarcoma: a single-center study.
Demir D; Hekimgil M; Karaca E; Ulusoy Y; Özdemir HH; Saydam G; Durmaz B; Akın H; Çetingül N; Tombuloğlu M; Özsan N
J Clin Pathol; 2023 Apr; 76(4):244-251. PubMed ID: 35927017
[TBL] [Abstract][Full Text] [Related]
17. Granulocytic sarcoma in MLL-positive infant acute myelogenous leukemia: fluorescence in situ hybridization study of childhood acute myelogenous leukemia for detecting MLL rearrangement.
Park KU; Lee DS; Lee HS; Kim CJ; Cho HI
Am J Pathol; 2001 Dec; 159(6):2011-6. PubMed ID: 11733351
[TBL] [Abstract][Full Text] [Related]
18. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.
Claerhout H; Van Aelst S; Melis C; Tousseyn T; Gheysens O; Vandenberghe P; Dierickx D; Boeckx N
Eur J Haematol; 2018 Jun; 100(6):603-612. PubMed ID: 29532520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
